Michael Hopp

Academic / Other · 2 registered clinical trials.

Status	Trial	Phase	Started
Active Not Recruiting	Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cance Small Cell Lung Cancer Limited Stage	Phase 2	2020-12-21
Active Not Recruiting	AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFR Non-squamous NSCLC	Phase 4	2020-09-11